Three-dose schedule: Administer a dose (0.5 mL) at 0, 1-2, and 6 months. The choice of dosing schedule may depend on the risk of exposure and the individual’s susceptibility to meningococcal serogroup B disease. 2.2 Administration Shake the syringe immediately before use to form a homogeneo...
The NadA component is a fragment of the full-length protein derived fromN. meningitidisstrain 2996 (peptide8 variant 2/3)5. The NHBA component is a recombinant fusion protein comprised of NHBA (peptide 2)5andaccessoryprotein 953 derived fromN. meningitidisstrains NZ98/254 and 2996, respectively...